U.S. Court of Appeals for the Federal Circuit
Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC
This writing
- Type
- Dissent
- Filed
- Feb. 6, 2019
- Case
- Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Newman, Circuit Judge, dissenting. Until discovery of the diagnostic method described in U.S. Patent No. 7,267,820 ("the '820 patent"), some 20% of patients suffering from the neurological disorderMyasthenia Gravis were not capable of being diagnosed. My colleagues rule that this new diagnostic…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | Feb. 6, 2019 |
| Opinion of the Court | Not attributed | Feb. 6, 2019 |